Imricor Medical SystemsASX:IMR +4.48%47 Days Inventory is 141.10 as of Dec. 2025, which is 64% below its 10-year median of 387.16. GuruFocus rates ASX:IMR with a GF Score™ of 47/100 and a GF Value™ of A$0.10 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Imricor Medical Systems ranks worse than 59.09% on this metric.
The historical rank and industry rank for Imricor Medical Systems's Days Inventory or its related term are showing as below:
ASX:IMR'
s Days Inventory Range Over the Past 10 Years
Min: 203.39 Med: 387.16 Max: 762.91
Current: 203.39
During the past 8 years, Imricor Medical Systems's highest Days Inventory was 762.91. The lowest was 203.39. And the median was 387.16.
ASX:IMR's Days Inventory is ranked worse than 59.09% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.73
vs ASX:IMR: 203.39
Imricor Medical Systems's Days Inventory
declined
from Dec. 2024 (319.81) to Dec. 2025 (141.10).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Imricor Medical Systems's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Imricor Medical Systems's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 12.32.
Imricor Medical Systems (ASX:IMR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Imricor Medical Systems's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Imricor Medical Systems's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Imricor Medical Systems Days Inventory Related Terms
Imricor Medical Systems Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:IMR vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Imricor Medical Systems's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imricor Medical Systems Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's Days Inventory distribution charts can be found below:
* The bar in red indicates where Imricor Medical Systems's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imricor Medical Systems (ASX:IMR) has a Days Inventory of 141.10 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Imricor Medical Systems and its competitors. This is 64% below median its historical median of 387.16. Over the past decade, Imricor Medical Systems' Days Inventory has ranged from 203.39 to 762.91. According to the industry distribution chart, Imricor Medical Systems ranks #465 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 59.1%.
Is Imricor Medical Systems' Days Inventory too high?
Imricor Medical Systems' current Days Inventory of 141.10 is 64% below median its 10-year median of 387.16. Over the past 10 years, this metric has ranged from a low of 203.39 to a high of 762.91. The Medical Devices & Instruments industry median Days Inventory is 179.73. Imricor Medical Systems' value of 141.10 is 21.5% below this industry median. Based on the distribution chart, Imricor Medical Systems ranks #465 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Imricor Medical Systems has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Imricor Medical Systems' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Imricor Medical Systems ranks #465 out of 787 companies for Days Inventory. This places Imricor Medical Systems in the lower half of its industry. The industry median Days Inventory is 179.73. Imricor Medical Systems' value of 141.10 is 21.5% below this benchmark. Historically, Imricor Medical Systems' own Days Inventory has ranged from 203.39 to 762.91 over the past decade. While the company's 10-year median is 387.16 vs. the industry median of 179.73, Imricor Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.73, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imricor Medical Systems's current Days Inventory of 141.10 is 21.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Imricor Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imricor Medical Systems's current Days Inventory is 141.10, which is 64% below median its own 10-year median of 387.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imricor Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Imricor Medical Systems (ASX:IMR) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.10, compared to a current price of A$1.87 — trading 1765% above its estimated fair value. The current Days Inventory is 141.10, which is 64% below median its 10-year median of 387.16 and 21.5% below the Medical Devices & Instruments industry median of 179.73. Imricor Medical Systems' overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Imricor Medical Systems (ASX:IMR), the current Days Inventory is 141.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Imricor Medical Systems (ASX:IMR) Overvalued in 2026?
Based on GuruFocus' analysis, Imricor Medical Systems stock appears to be overvalued.
The current stock price of A$1.87 is trading 1765% above its estimated GF Value™ of A$0.10.
GuruFocus considers Imricor Medical Systems to be Significantly Overvalued.
Key valuation signals for ASX:IMR:
Days Inventory: 141.10 (64% below median its 10-year median of 387.16)
GF Value™: A$0.10 vs. price of A$1.87 (1765% above fair value)
Industry Position: 21.5% below the Medical Devices & Instruments median (#465 of 787)
No single metric tells the full story. See the ASX:IMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe.
47GF Score
Get the complete analysis for ASX:IMR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IMR has been successfully added to your 
